Mannatech, Incorporated (NASDAQ:MTEX – Get Free Report) saw a significant decrease in short interest in the month of June. As of June 30th, there was short interest totaling 11,358 shares, a decrease of 60.3% from the June 15th total of 28,596 shares. Based on an average daily volume of 25,175 shares, the days-to-cover ratio is currently 0.5 days. Approximately 1.0% of the company’s stock are short sold.
Mannatech Stock Down 3.8%
MTEX traded down $0.18 on Tuesday, hitting $4.56. The company’s stock had a trading volume of 8,606 shares, compared to its average volume of 23,792. The company’s 50 day simple moving average is $5.15 and its 200-day simple moving average is $6.23. The firm has a market cap of $8.80 million, a P/E ratio of -0.68 and a beta of 0.72. Mannatech has a 12 month low of $3.80 and a 12 month high of $12.45.
Mannatech (NASDAQ:MTEX – Get Free Report) last announced its quarterly earnings results on Thursday, May 14th. The company reported $0.49 earnings per share for the quarter. Mannatech had a negative return on equity of 2,383.34% and a negative net margin of 11.97%.The firm had revenue of $24.92 million for the quarter.
Analyst Upgrades and Downgrades
Get Our Latest Report on Mannatech
Insider Activity
In other Mannatech news, Director Kevin Andrew Robbins acquired 7,100 shares of the stock in a transaction on Tuesday, May 19th. The shares were purchased at an average price of $4.17 per share, for a total transaction of $29,607.00. Following the completion of the acquisition, the director owned 33,333 shares in the company, valued at approximately $138,998.61. This represents a 27.07% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In the last quarter, insiders acquired 14,903 shares of company stock valued at $62,155. 41.50% of the stock is owned by company insiders.
Mannatech Company Profile
Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.
The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.
See Also
- Five stocks we like better than Mannatech
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
